Qilian International Holding Group Limited QLI
Set alert
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 38.68M
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- 0.00
- Beta
- 1.41
- Short ratio
- 0.76
- Inst. own
- 0.04%
- Dividend
- 0.00
- Ex-div date
- Feb 26, 2023
- 50-d avg
- 5.10
- 200-d avg
- 3.57
- 1y target
- 0.00
Key statistics
- Market cap
- 38.68M
- Enterprise value
- 18.40M
- Trailing P/E
- 0.00
- Forward P/E
- 0.00
- PEG ratio
- 0.00
- Price / sales
- 0.83
- Price / book
- 0.90
- EPS (TTM)
- -1.10
- Beta
- 1.41
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -16.74%
- Revenue (TTM)
- 46.47M
- Revenue growth
- -47.20%
- Free cash flow
- -1.96M
- Total cash
- 22.42M
- Total debt
- 577.85K
- Return on equity
- -16.36%
- Shares outstanding
- 7.15M
- Short % of float
- 1.79%
- 50-day average
- 5.10
- 200-day average
- 3.57
Analyst view
Consensus: none
Next earnings
Consensus EPS estimate 0.00.
Financials — quick view
About Qilian International Holding Group Limited
Qilian International Holding Group Limited manufactures and distributes active pharmaceutical ingredients (APIs), traditional Chinese medicine derivatives (TCMD), and other by-products in China. The company provides licorice products, including Gan Di Xin, an antitussive and expectorant medicine; Qilian Shan Licorice Extract, an ingredient for pharmaceutical companies to manufacture traditional licorice tablets; and Qilian Shan licorice liquid extract, a primary ingredient for medical preparation companies to produce compound licorice oral solutions. It offers Qilian Shan oxytetracycline tablets to prevent and treat a range of diseases in chickens, turkeys, cattle, swine, and human; and Qilian Shan oxytetracycline APIs for pharmaceutical companies to manufacture medications. In addition, the company offers TCMD products, such as Ahan antibacterial paste to treat refractory chronic skin diseases; heparin products, including heparin sodium preparations for pharmaceutical companies to produce medications for cardiovascular diseases, cerebrovascular diseases, and hemodialysis; and Zhu Xiaochang sausage casings, which are natural food products for culinary application. Further, it provides Xiongguan organic fertilizers to improve crop yield and soil's chemical properties and reduce soil compaction; and Xiongguan organic-inorganic compound fertilizers to increased plant growth. Qilian International Holding Group Limited was incorporated in 2019 and is based in Jiuquan, the People's Republic of China.
- Sector
- Healthcare
- Industry
- Drug Manufacturers—Specialty & Generic
- Country
- China
- Website
- qlsyy.net
News
- 12 Health Care Stocks Moving In Friday's After-Market Session
- Why Amazon Shares Traded Lower; Here Are 74 Biggest Movers From Yesterday
- Stocks That Hit 52-Week Lows On Monday
- Why MSP Recovery Is Trading Higher By Over 21%, Here Are 61 Stocks Moving In Monday's Mid-Day Session
- Why Blue Water Vaccines Is Trading Higher By Around 80%, Here Are 61 Stocks Moving In Wednesday's Mid-Day Session
- Stocks That Hit 52-Week Lows On Tuesday
- Stocks That Hit 52-Week Lows On Wednesday
- Stocks That Hit 52-Week Lows On Thursday
- 80 Biggest Movers From Yesterday
Your note
Sign in to keep a note on QLI — it syncs with the Stock Master app.
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Geode Capital Management, LLC | 0.07% | 23,641 | 20.57K | Jun 29, 2023 |
| Morgan Stanley | 0.01% | 1,794 | 1.56K | Jun 29, 2023 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity NASDAQ Composite Index Fund | 0.07% | 23,641 | 21.28K | May 30, 2023 |